Milestone Pharmaceuticals (MIST) Invested Capital (2023 - 2026)

Milestone Pharmaceuticals' Invested Capital history runs 4 years deep, the most recent figure standing at $50.0 million for Q1 2026.

• Quarterly Invested Capital changed 0.0% year-over-year to $50.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $50.0 million, changed 0.0% from the prior year.
• Invested Capital was $50.0 million for Q1 2026 at Milestone Pharmaceuticals, roughly flat from $50.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $50.0 million in Q1 2023 and bottomed at $50.0 million in Q1 2023.
• A 4-year average of $50.0 million and a median of $50.0 million in 2023 frame the typical range for Invested Capital.
• Peak annual rise in Invested Capital reached 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
• Milestone Pharmaceuticals' Invested Capital stood at $50.0 million in 2023, then changed by 0.0% to $50.0 million in 2024, then changed by 0.0% to $50.0 million in 2025, then changed by 0.0% to $50.0 million in 2026.
• Business Quant data shows MIST's Invested Capital at $50.0 million in Q1 2026, $50.0 million in Q4 2025, and $50.0 million in Q3 2025.